Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05051813 · ClinicalTrials.gov registry record

The Heidelberg Engineering ANTERION Corneal Epithelium Thickness Precision and Agreement Study

A clinical trial, sponsored by Heidelberg Engineering.

Completed
Registry status
151
Enrollment target

NCT05051813 is a clinical trial that has completed, run by Heidelberg Engineering. The registered enrollment target is 151 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05051813 has completed, sponsored by Heidelberg Engineering.

COMPLETED
Registry status
151 participants
Enrollment target

Study Summary

This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess corneal epithelial thickness parameters with the ANTERION

Interventions

  • DEVICE ANTERION

Trial Details

FieldValue
Enrollment Target 151 participants
Start Date 2021-09-07
Est. Completion 2024-12-16

Sponsor

Heidelberg Engineering

16 total trials

What the Registry Record Tells You About NCT05051813

The ClinicalTrials.gov registry entry for NCT05051813 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Heidelberg Engineering, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which ANTERION is the first listed.

NCT05051813 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05051813 about?

NCT05051813 is a clinical study titled "The Heidelberg Engineering ANTERION Corneal Epithelium Thickness Precision and Agreement Study". This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess corneal epithelial thickness parameters with the ANTERION

What is the current status of trial NCT05051813?

This trial is currently completed. The enrollment target is 151 participants. The study started on 2021-09-07. Estimated completion is 2024-12-16.

What interventions are being tested in trial NCT05051813?

The interventions under investigation include: ANTERION (DEVICE).

Who is sponsoring clinical trial NCT05051813?

This trial is sponsored by Heidelberg Engineering, which has 16 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.